Wakamoto Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -6.58% vs -11.33% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -45.08% vs -96.51% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,425.50",
          "val2": "2,596.40",
          "chgp": "-6.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-6.40",
          "val2": "182.00",
          "chgp": "-103.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.70",
          "val2": "1.10",
          "chgp": "54.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.70",
          "val2": "12.20",
          "chgp": "-45.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-56.20%",
          "val2": "26.10%",
          "chgp": "-8.23%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 27.18% vs 0.66% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 252.80% vs -40.92% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9,906.80",
          "val2": "7,789.50",
          "chgp": "27.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "626.20",
          "val2": "-94.60",
          "chgp": "761.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.90",
          "val2": "0.90",
          "chgp": "111.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-1.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "227.20",
          "val2": "64.40",
          "chgp": "252.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.80%",
          "val2": "-58.80%",
          "chgp": "8.46%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

2,425.50

2,596.40

-6.58%

Operating Profit (PBDIT) excl Other Income

-6.40

182.00

-103.52%

Interest

1.70

1.10

54.55%

Exceptional Items

0.00

0.00

Consolidate Net Profit

6.70

12.20

-45.08%

Operating Profit Margin (Excl OI)

-56.20%

26.10%

-8.23%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is -6.58% vs -11.33% in Mar 2026

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is -45.08% vs -96.51% in Mar 2026

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

9,906.80

7,789.50

27.18%

Operating Profit (PBDIT) excl Other Income

626.20

-94.60

761.95%

Interest

1.90

0.90

111.11%

Exceptional Items

0.00

-1.30

100.00%

Consolidate Net Profit

227.20

64.40

252.80%

Operating Profit Margin (Excl OI)

25.80%

-58.80%

8.46%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 27.18% vs 0.66% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 252.80% vs -40.92% in Mar 2025

All Annual Results